Testing effectiveness (Phase 2)Ended earlyNCT04926181
What this trial is testing
Apalutamide Plus Cetrelimab in Patients With Treatment-Emergent Small Cell Neuroendocrine Prostate Cancer
Who this might be right for
Small Cell Neuroendocrine CarcinomaProstate CancerSmall Cell Carcinoma
Rahul Aggarwal 2